Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 17/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1712185 | 1.00 | GRM2 (0.50) | GRM2 | |
| SCHEMBL1711842 | 0.93 | GRM2 (0.51) | GRM2 | |
| SCHEMBL2290523 | 0.93 | GRM2 (0.51) | GRM2 | |
| SCHEMBL12728925 | 0.83 | GRM2 (0.60) | GRM2 | |
| SCHEMBL13298874 | 0.82 | GRM2 (0.49) | GRM2 | |
| SCHEMBL8695799 | 0.82 | GRM2 (0.59) | GRM2 | |
| SCHEMBL8798953 | 0.82 | GRM2 (0.57) | GRM2 | |
| SCHEMBL7543143 | 0.82 | GRM2 (0.57) | GRM2 | |
| SCHEMBL7292670 | 0.82 | GRM2 (0.59) | GRM2 | |
| SCHEMBL6966303 | 0.82 | GRM2 (0.59) | GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195961-A1 | TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195961-A1 | TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS | HRH3, OXA1L, HRH1 | GRM2 2558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.